신경자극 기기 시장 규모, 점유율, 동향, 산업 분석 보고서 : 용도별, 기기별, 지역별 - 시장 예측(2025-2034년)

The global neurostimulation devices market size is expected to reach USD 23.63 billion by 2034, according to a new study by Polaris Market Research. The report "Neurostimulation Devices Market Size, Share, Trends, Industry Analysis Report: By Application (Pain Management, Epilepsy, Essential Tremor, Urinary & Faecal Incontinence, and Depression), Devices, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The neurostimulation devices market consists of medical devices that deliver electrical impulses to the nervous system to modulate neural activity, primarily used for managing chronic pain, epilepsy, Parkinson's disease, essential tremor, and other neurological conditions.

The market is experiencing significant growth due to the rising prevalence of neurological disorders, increasing demand for minimally invasive treatment options, and advancements in technology, including AI integration and wireless stimulation. Neurostimulation devices market opportunities lie in expanding applications beyond traditional indications, such as in cognitive disorders and obesity management, along with the growing adoption of these devices in emerging markets.

Key trends include the development of rechargeable and miniaturized devices, strategic collaborations among industry players, and regulatory approvals facilitating neurostimulation devices market expansion. As healthcare infrastructure improves and awareness increases, the market continues to witness steady growth, driven by innovation and evolving patient needs.

Neurostimulation Devices Market Report Highlights

By application, the pain management segment holds the largest market share due to the rising prevalence of chronic pain conditions and the increasing adoption of spinal cord stimulators.

By devices, the deep brain stimulators segment is experiencing the fastest growth, supported by their expanding use in movement disorders such as Parkinson's disease and essential tremor.

North America leads the market due to high healthcare spending, strong regulatory approvals, and widespread adoption of neurostimulation devices.

Asia Pacific is experiencing significant growth, driven by improving healthcare infrastructure, rising awareness, and increasing prevalence of neurological disorders.

The neurostimulation devices market features several key players actively contributing to advancements in medical technology. Prominent companies include Abbott Laboratories; Aleva Neurotherapeutics; Boston Scientific Corporation; Cognito Therapeutics; ElectroCore, Inc.; LivaNova PLC; Medtronic plc; Nalu Medical, Inc.; Neuronetics, Inc.; NeuroPace, Inc.; Nevro Corp.; and Synapse Biomedical Inc.

Polaris Market Research has segmented the neurostimulation devices market report on the basis of application, devices, and region:

By Application Outlook (Revenue - USD Billion, 2020-2034)

Pain Management

Epilepsy

Essential Tremor

Urinary & Faecal Incontinence

Depression

By Devices Outlook (Revenue - USD Billion, 2020-2034)

Spinal Cord Stimulator

Deep Brain Stimulator

Sacral Nerve Stimulator

Vagus Nerve Stimulator

Gastric Electric Stimulator

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Neurostimulation Devices Market Insights

• 4.1. Neurostimulation Devices Market - Market Snapshot
• 4.2. Neurostimulation Devices Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Rising Prevalence of Neurological Disorders
    • 4.2.1.2. Advancements in Neurostimulation Technology
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. High Cost of Devices and Procedures
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Neurostimulation Devices Market Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Neurostimulation Devices Market, by Application

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
• 5.3. Pain Management
  • 5.3.1. Global Neurostimulation Devices Market, by Pain Management, by Region, 2020-2034 (USD Billion)
• 5.4. Epilepsy
  • 5.4.1. Global Neurostimulation Devices Market, by Epilepsy, by Region, 2020-2034 (USD Billion)
• 5.5. Essential Tremor
  • 5.5.1. Global Neurostimulation Devices Market, by Essential Tremor, by Region, 2020-2034 (USD Billion)
• 5.6. Urinary & Faecal Incontinence
  • 5.6.1. Global Neurostimulation Devices Market, by Urinary & Faecal Incontinence, by Region, 2020-2034 (USD Billion)
• 5.7. Depression
  • 5.7.1. Global Neurostimulation Devices Market, by Depression, by Region, 2020-2034 (USD Billion)

6. Global Neurostimulation Devices Market, by Devices

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
• 6.3. Spinal Cord Stimulator
  • 6.3.1. Global Neurostimulation Devices Market, by Spinal Cord Stimulator, by Region, 2020-2034 (USD Billion)
• 6.4. Deep Brain Stimulator
  • 6.4.1. Global Neurostimulation Devices Market, by Deep Brain Stimulator, by Region, 2020-2034 (USD Billion)
• 6.5. Sacral Nerve Stimulator
  • 6.5.1. Global Neurostimulation Devices Market, by Sacral Nerve Stimulator, by Region, 2020-2034 (USD Billion)
• 6.6. Vagus Nerve Stimulator
  • 6.6.1. Global Neurostimulation Devices Market, by Vagus Nerve Stimulator, by Region, 2020-2034 (USD Billion)
• 6.7. Gastric Electric Stimulator
  • 6.7.1. Global Neurostimulation Devices Market, by Gastric Electric Stimulator, by Region, 2020-2034 (USD Billion)

7. Global Neurostimulation Devices Market, by Geography

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Neurostimulation Devices Market Assessment, By Geography, 2020-2034 (USD Billion)
• 7.3. Neurostimulation Devices Market - North America
  • 7.3.1. North America: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • 7.3.2. North America: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.3.3. Neurostimulation Devices Market - U.S.
    • 7.3.3.1. U.S.: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.3.3.2. U.S.: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.3.4. Neurostimulation Devices Market - Canada
    • 7.3.4.1. Canada: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.3.4.2. Canada: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
• 7.4. Neurostimulation Devices Market - Europe
  • 7.4.1. Europe: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • 7.4.2. Europe: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.4.3. Neurostimulation Devices Market - UK
    • 7.4.3.1. UK: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.4.3.2. UK: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.4.4. Neurostimulation Devices Market - France
    • 7.4.4.1. France: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.4.4.2. France: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.4.5. Neurostimulation Devices Market - Germany
    • 7.4.5.1. Germany: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.4.5.2. Germany: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.4.6. Neurostimulation Devices Market - Italy
    • 7.4.6.1. Italy: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.4.6.2. Italy: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.4.7. Neurostimulation Devices Market - Spain
    • 7.4.7.1. Spain: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.4.7.2. Spain: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.4.8. Neurostimulation Devices Market - Netherlands
    • 7.4.8.1. Netherlands: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.4.8.2. Netherlands: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.4.9. Neurostimulation Devices Market - Russia
    • 7.4.9.1. Russia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.4.9.2. Russia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.4.10. Neurostimulation Devices Market - Rest of Europe
    • 7.4.10.1. Rest of Europe: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.4.10.2. Rest of Europe: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
• 7.5. Neurostimulation Devices Market - Asia Pacific
  • 7.5.1. Asia Pacific: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • 7.5.2. Asia Pacific: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.5.3. Neurostimulation Devices Market - China
    • 7.5.3.1. China: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.5.3.2. China: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.5.4. Neurostimulation Devices Market - India
    • 7.5.4.1. India: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.5.4.2. India: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.5.5. Neurostimulation Devices Market - Malaysia
    • 7.5.5.1. Malaysia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.5.5.2. Malaysia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.5.6. Neurostimulation Devices Market - Japan
    • 7.5.6.1. Japan: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.5.6.2. Japan: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.5.7. Neurostimulation Devices Market - Indonesia
    • 7.5.7.1. Indonesia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.5.7.2. Indonesia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.5.8. Neurostimulation Devices Market - South Korea
    • 7.5.8.1. South Korea: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.5.8.2. South Korea: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.5.9. Neurostimulation Devices Market - Australia
    • 7.5.9.1. Australia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.5.9.2. Australia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.5.10. Neurostimulation Devices Market - Rest of Asia Pacific
    • 7.5.10.1. Rest of Asia Pacific: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.5.10.2. Rest of Asia Pacific: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
• 7.6. Neurostimulation Devices Market - Middle East & Africa
  • 7.6.1. Middle East & Africa: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • 7.6.2. Middle East & Africa: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.6.3. Neurostimulation Devices Market - Saudi Arabia
    • 7.6.3.1. Saudi Arabia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.6.3.2. Saudi Arabia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.6.4. Neurostimulation Devices Market - UAE
    • 7.6.4.1. UAE: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.6.4.2. UAE: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.6.5. Neurostimulation Devices Market - Israel
    • 7.6.5.1. Israel: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.6.5.2. Israel: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.6.6. Neurostimulation Devices Market - South Africa
    • 7.6.6.1. South Africa: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.6.6.2. South Africa: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.6.7. Neurostimulation Devices Market - Rest of Middle East & Africa
    • 7.6.7.1. Rest of Middle East & Africa: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.6.7.2. Rest of Middle East & Africa: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
• 7.7. Neurostimulation Devices Market - Latin America
  • 7.7.1. Latin America: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • 7.7.2. Latin America: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.7.3. Neurostimulation Devices Market - Mexico
    • 7.7.3.1. Mexico: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.7.3.2. Mexico: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.7.4. Neurostimulation Devices Market - Brazil
    • 7.7.4.1. Brazil: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.7.4.2. Brazil: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.7.5. Neurostimulation Devices Market - Argentina
    • 7.7.5.1. Argentina: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.7.5.2. Argentina: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.7.6. Neurostimulation Devices Market - Rest of Latin America
    • 7.7.6.1. Rest of Latin America: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.7.6.2. Rest of Latin America: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)

8. Competitive Landscape

• 8.1. Expansion and Acquisition Analysis
  • 8.1.1. Expansion
  • 8.1.2. Acquisitions
• 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

• 9.1. Abbott Laboratories
  • 9.1.1. Company Overview
  • 9.1.2. Financial Performance
  • 9.1.3. Product Benchmarking
  • 9.1.4. Recent Development
• 9.2. Advanced Bionics (a Sonova Group company)
  • 9.2.1. Company Overview
  • 9.2.2. Financial Performance
  • 9.2.3. Product Benchmarking
  • 9.2.4. Recent Development
• 9.3. Aleva Neurotherapeutics
  • 9.3.1. Company Overview
  • 9.3.2. Financial Performance
  • 9.3.3. Product Benchmarking
  • 9.3.4. Recent Development
• 9.4. Boston Scientific Corporation
  • 9.4.1. Company Overview
  • 9.4.2. Financial Performance
  • 9.4.3. Product Benchmarking
  • 9.4.4. Recent Development
• 9.5. Cochlear Limited
  • 9.5.1. Company Overview
  • 9.5.2. Financial Performance
  • 9.5.3. Product Benchmarking
  • 9.5.4. Recent Development
• 9.6. Cognito Therapeutics
  • 9.6.1. Company Overview
  • 9.6.2. Financial Performance
  • 9.6.3. Product Benchmarking
  • 9.6.4. Recent Development
• 9.7. ElectroCore, Inc.
  • 9.7.1. Company Overview
  • 9.7.2. Financial Performance
  • 9.7.3. Product Benchmarking
  • 9.7.4. Recent Development
• 9.8. Inspire Medical Systems, Inc.
  • 9.8.1. Company Overview
  • 9.8.2. Financial Performance
  • 9.8.3. Product Benchmarking
  • 9.8.4. Recent Development
• 9.9. LivaNova PLC
  • 9.9.1. Company Overview
  • 9.9.2. Financial Performance
  • 9.9.3. Product Benchmarking
  • 9.9.4. Recent Development
• 9.10. Medtronic plc
  • 9.10.1. Company Overview
  • 9.10.2. Financial Performance
  • 9.10.3. Product Benchmarking
  • 9.10.4. Recent Development